Pathodynamics of nitric oxide production within implanted glioma studied with an in vivo microdialysis technique and immunohistochemistry

Journal Pharmacological Sciences

Volumn 91, Issue 1, 2003, Pages 15-22

  Oyoshi, Tatsuki ^a   Nomoto, Masahiro ^b   Hirano, Hirofumi ^a   Kuratsu, Jun Ichi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Glioma; Macrophage; Microdialysis; Nitric oxide; Nitric oxide synthase

Indexed keywords

2 AMINO 5,6 DIHYDRO 6 METHYL 4H 1,3 THIAZINE; ARGININE; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INTERACTION; CELLULAR DISTRIBUTION; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; DIALYSATE; GLIOMA; GLIOMA CELL; IMMUNOHISTOCHEMISTRY; IMPLANT; IN VIVO STUDY; INHIBITION KINETICS; MACROPHAGE; MALE; MICRODIALYSIS; MICROGLIA; MOLECULAR DYNAMICS; MOLECULAR RECOGNITION; NONHUMAN; PATHOGENESIS; RAT; TUMOR GROWTH;

ANIMALS; BRAIN NEOPLASMS; ENZYME INHIBITORS; GLIOMA; HALF-LIFE; IMMUNOHISTOCHEMISTRY; MALE; MICRODIALYSIS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PARAFFIN EMBEDDING; RATS; RATS, WISTAR; THIAZINES;

EID: 0037716714     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.91.15     Document Type: Article

References (37)

1. Moncada S, Palmer RMJ and Higgs EA: Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 43. 109-142 (1991)
2. Iadecola C, Zhang F and Xu X: Role of nitric oxide synthase-containing vascular nerves in cerebrovasodilation elicited from cerebellum. Am J Physiol 264, 738-746 (1993)
3. Yamada K, Noda Y, Nakayama T: Role of nitric oxide in learning and memory and in monoamine metabolism in the rat brain. Br J Pharmacol 115, 852-858 (1995)
4. Yamada K, Noda Y, Hasegawa T, Komori Y, Nikai T, Sugihara H and Nabeshima T: The role of nitric oxide in dizocilpine-induced impairment of spontaneous alternation behavior in mice. J Pharmacol Exp Ther 276, 460-466 (1996)
5. Yamada K, Hiramatsu M, Noda Y, Mamiya T, Murai M, Kameyama T, Komori Y, Nikai T, Sugihara H and Nabeshima T: Role of nitric oxide and cyclic GMP in the dizocilpine-induced impairment of spontaneous alternation behavior in mice. Neuroscience 74, 365-374 (1996)
6. Christopherson KS and Bredt DS: Nitric oxide in excitable tissue: Physiological roles and disease. J Clin Invest 100, 2424-2429 (1997)
7. Schuman EM and Madison DV: Nitric oxide and synaptic function. Ann Res Neurosci 17, 153-183 (1994)
8. Hibbs JB Jr, Vavrin Z and Taintor RL: L-Arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immunol 138, 550-565 (1987)
9. Keller R, Geiges M and Keist R: L-Arginine-dependent reactive nitrogen intermediates as mediators of tumor cell killing by activated macrophages. Cancer Res 50, 1421-1425 (1990)
10. Roggendorf W, Strupp S and Paulus W: Distribution adn characterization of microglia/macrophages in human brain tumors. Acta Neuropathol (Berl) 92, 288-293 (1996)
11. Bakshi A, Nag TC, Wadhwa S, Mahapatra AK and Sarkar C: The expression of nitric oxide synthases in human brain tumours and peritumoral areas. J Neurol Sci 155, 196-203 (1998)
12. Cobbs CS, Brenman JE, Aldape KD, Bredt DS and Israel MA: Expression of nitric oxide synthase in human central nervous system tumours. Cancer Res 55, 727-730 (1995)
13. Fenoglio C, Necchi D, Civallero M, Ceroni M and Nano R: Cytochemical demonstration of nitric oxide synthase and 5′ nucleotidase in human glioblastoma. Anticancer Res 17, 2507-2511 (1997)
14. Anggard E: Nitric oxide: Mediator, murderer, and medicine. Lancet 343, 1199-1206 (1994)
15. Chin K, Kurashima Y, Ogura T, Tajiri H,Yoshida S and Esumi H: Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells. Oncogene 15, 437-442 (1997)
16. Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, Rhodes P, Westmore K, Emson PC and Moncada S: Role of nitric oxide in tumor growth. Proc Natl Acad Sci USA 92, 4392-4396 (1995)
17. Whittle IR, Collins F, Kelly PAT, Ritchie I and Ironside JW: Nitric oxide synthase is expressed in experimental malignant glioma and influences tumour blood-flow. Acta Neurochir (Wien) 138, 870-875 (1996)
18. Miura K, Yamasaka S, Ebara T, Okumura M, Imanishi M, Kim S, Nakatani T and Iwao H: Effects of nitric oxide scavenger, carboxy-PTIO on endotoxin-induced alterations in systemic hemodynamics in rats. Jpn J Pharmacol 82, 261-264 (2000)
19. Prosperi C, Scali C, Pepeu G and Casamenti F: NO-flurbiprofen attenuates excitotoxin-induced brain inflammation, and releases nitric oxide in the brain. Jpn J Pharmacol 86, 230-235 (2001)
20. Okamura T, Ayajiki K, Fujioka H, Shinozaki K and Toda N: Neurogenic cerebral vasodilation mediated by nitric oxide. Jpn J Pharmacol 88, 32-38 (2002)
21. Yamada K and Nabeshima T: Simultaneous measurement of nitrite and nitrate levels as indices of nitric release in the cerebellum of conscious rats. J Neurochem 68, 1234-1243 (1997)
22. Privat C, Lantoine F, Bedioui F, Millanvoye Van Brussel E, Devynck J and Devynck MA: Nitric oxide production by endothelial cells: Comparison of three methods of quantification. Life Sci 61, 1193-1202 (1997)
23. Moriyama A, Masumoto A, Nanri H, Tabaru A, Unoki H, Imoto I, Ikeda M and Otsuki M: High plasma concentrations of nitrite/nitrate in patients with hepatocellular carcinoma. Am J Gastroenterol 92, 1520-1523 (1997)
24. Eroglu A, DemirciK S, Ayyildiz A, Kocaoglu H, Akbulut H, Akgul H and Elhan HA: Serum concentrations of vascular endothelial growth factor and nitrite as an estimate of in vivo nitric oxide in patients with gastric cancer. Br J Cancer 80, 1630-1634 (1999)
25. Thomsen LL, Lawton FG, Knowles RG, Beesley JE, Riveros-Moresno V and Moncada S: Nitric oxide synthase activity in human gynecological cancer. Cancer Res 54, 1352-1354 (1994)
26. Gallo O, Masini E, Morbidelli L, Franchi A, Fini-Storchi I, Vergari WA and Ziche M: Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J Natl Cancer Inst 90, 587-596 (1998)
27. Miles DW, Happerfield LC, Thomseno LL and Filipe I: Nitric oxide synthase activity and localization in gastric carcinoma. Proc Am Assoc Cancer Res 37, 155 (1996)
28. Iwata S, Nakagawa K, Harada H, Oka Y, Kumon Y and Sakaki S: Endothelial nitric oxide synthase expression in tumor vascularture is correlated with malignancy in human supratentorial astrocytic tumors. Neurosurgery 45, 24-28 (1999)
29. Hibbs JB Jr, Taintor RR, Vavrin Z and Rachlin EM: Nitric oxide: A cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 157, 87-94 (1988)
30. Drapier JC, Wietzerbin J and Hibbs JB Jr: Interferon-γ and tumour necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages. Eur J Immunol 18, 1587-1592 (1988)
31. Thomsen LL, Baguley BC and Wilson WR: Nitric order. Its production in host-cell-infiltrated EMT6 spheroids and its role in tumour cell killing by flavone-8-acetic acid and 5, 6-dimethylxanthenone-4-acetic acid. Cancer Chemother Pharmacol 31, 151-155 (1992)
32. Kurimoto M, Endo S, Hirashima Y, Hamada H, Ogiichi T and Takaku A: Growth inhibition and radiosensitization of cultured glioma cells by nitric oxide generating agents. J Neurooncol 42, 35-44 (1999)
33. Nakano S, Matsukado K and Black KL: Increased brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide. Cancer Res 56, 4027-4031 (1996)
34. Swaroop GR, Kelly PA, Bell HS, Shinoda J, Yamaguchi S and Whittle IR: The effects of chronic nitric oxide synthase suppression on glioma pathophysiology. Br J Neurosurg 14, 543-548 (2000)
35. Swaroop GR, Malcolm GP, Kelly PA, Ritchie I and Whittle IR: Effects of nitric oxide modulation on tumour blood flow and microvascular permeability in C6 glioma. Neuroreport 9, 2577-2581 (1998)
36. Andrade S, Hart I and Piper P: Inhibitors of nitric oxide synthase selectively reduce flow in tumour-associated neovasculature. Br J Pharmacol 107, 1092-1095 (1992)
37. Wood PJ, Stratford IJ, Adams GE, Szabo C, Thiemermann C and Vane JR: Modification of energy metabolism and radiation response of a murine tumour by changes in nitric oxide availability. Biochem Biophys Res Commun 192, 505 - 510 (1993)